Microsurgical autologous breast reconstruction in the midst of a pandemic: A single-unit COVID-19 experience.

Journal of plastic, reconstructive & aesthetic surgery : JPRAS 2022 Vol.75(1) p. 112-117

Ho W, Köhler G, Haywood RM, Rosich-Medina A, Masud D

관련 도메인

Abstract

[INTRODUCTION] COVID-19 has disrupted the provision of breast reconstructive services throughout the UK. Autologous free flap breast reconstruction was restarted in our unit on 3 June 2020. We aimed to compare the unit's performance of microsurgical autologous breast reconstruction in the "post-COVID" period compared with the exact time period in the preceding year.

[METHODS] We retrospectively reviewed prospectively collected data in the "pre-COVID" (from 3 June 2019 to 31 December 2019) and "post-COVID" period (from 3 June 2020 to 31 December 2020). Patient demographics included age, body mass index, co-morbidities, Anaesthesiologists (ASA) grade and smoking status. Surgical factors included neoadjuvant chemotherapy, previous chest wall radiotherapy, unilateral or bilateral reconstruction, reconstruction timing, number of pedicles, contralateral symmetrisation and other procedures. dependant variables were ischaemic time, operative time, mastectomy weight, flap weight, length of stay, return to theatre and complication rates. The number of trainers and trainees present in theatre was recorded and analysed.

[RESULTS] Fewer DIEP flaps were performed in the "post-COVID" period (45 vs. 29). No significant difference was observed in mastectomy resection weight, but flap weight was significantly increased. No significant difference was found in ischaemic time as well. The postoperative length of stay was significantly reduced. No significant difference was found in rates of return to theatre, unplanned admission, infection, haematoma, seroma or wound dehiscence. No cases of venous thromboembolism or flap failures were recorded. The mean number of trainers and trainees, and the trainee-to-trainer ratio was not found to be significantly different between cohorts.

[CONCLUSION] Although fewer cases were performed, autologous breast reconstruction was safely delivered throughout the COVID-19 pandemic in the first wave without affecting training.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
해부 breast 유방 dict 5
시술 flap 피판재건술 dict 3
시술 free flap 피판재건술 dict 1
해부 bilateral scispacy 1
해부 pedicles scispacy 1
합병증 flap breast scispacy 1
합병증 wound scispacy 1
합병증 haematoma 혈종 dict 1
합병증 seroma 장액종 dict 1
합병증 infection 감염 dict 1
합병증 wound dehiscence 상처열개 dict 1
약물 ASA C0004057
aspirin
scispacy 1
약물 neoadjuvant C0600558
Neoadjuvant Therapy
scispacy 1
약물 [INTRODUCTION] COVID-19 scispacy 1
약물 COVID-19 scispacy 1
질환 venous thromboembolism C1861172
Venous Thromboembolism
scispacy 1
기타 Patient scispacy 1
기타 wall scispacy 1
기타 DIEP flaps scispacy 1

MeSH Terms

Breast Neoplasms; COVID-19; Female; Free Tissue Flaps; Humans; Length of Stay; Mammaplasty; Mastectomy; Microsurgery; Middle Aged; Pandemics; Retrospective Studies; SARS-CoV-2; Transplantation, Autologous; United Kingdom

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문